Nitroxide—HMP—Protects Human Trophoblast HTR-8/SVneo Cells from H2O2-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway
Antioxidants · 08.08.2023 · 12 (8) · 1578
DOI: 10.3390/antiox12081578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 08.08.2023. Verfasst von Diana Pintye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Beth Israel Lahey Health, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Massachusetts Life Science Center, Massachusetts Life Science Center (MLSC) USA–Women’s Health Innovation Grant.
Abstract (Originalsprache)
Preeclampsia (PE) is a pregnancy-specific syndrome affecting 5–7% of patients. There is no effective treatment available. Early abnormal placental development is associated with oxidative stress (OS) and a release of reactive oxygen species (ROS) in the placenta. This phenomenon leads to downstream signaling, Hypoxia Inducible Factor 1A (HIF1A) stabilization and transcription of the anti-angiogenic factors soluble fms-like tyrosine kinase 1 (sFLT1) and soluble endoglin (sEng), which are known to cause endothelial and trophoblast dysfunction and cardinal features of PE: hypertension, proteinuria and, in severe cases, eclampsia. We tested whether 3-(Hydroxymethyl)-1-oxy-2,2,5,5-tetramethylpyrrolidine (HMP)—a nitroxide-type antioxidant molecule—can reduce placental OS and mitigate PE symptoms in vitro. We induced OS in human trophoblast (HTR-8/SVneo) cells with hydrogen peroxide (H2O2) and assessed whether modulating cell redox function with HMP reduces cell injury, mitochondrial stress and HIF1A and sFLT1 production. Pre-treatment with HMP reduced mitochondrial-derived ROS production, restored LC3B expression and reduced HIF1A and sFLT1 expression in H2O2-exposed HTR-8/SVneo trophoblast cells. HMP improved the mitochondrial electron chain enzyme activity, indicating that a reduction in OS alleviates mitochondrial stress and also reduces anti-angiogenic responses. In reducing placental trophoblast OS, HMP presents a potential novel therapeutic approach for the treatment of PE. Future investigation is warranted regarding the in vivo use of HMP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Beth Israel Lahey Health, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
- Department of Obstetrics and Gynecology, Semmelweis University, 1085 Budapest, Hungary.
- Department of Chemistry, University of Massachusetts, Boston, MA 02125, USA.
- Department of Obstetrics and Gynecology, Beth Israel Lahey Health, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Réka Eszter Sziva, Zsuzsanna K Zsengellér
Förderung
- Massachusetts Life Science Center
- Massachusetts Life Science Center (MLSC) USA–Women’s Health Innovation Grant
Zitieren
APA
Pintye, D., Sziva, R. E., Mastyugin, M., Török, M., Jacas, S., Lo, A., Salahuddin, S., & Zsengellér, Z. K. (2023). Nitroxide—HMP—Protects Human Trophoblast HTR-8/SVneo Cells from H2O2-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway. Antioxidants, 12(8), 1578. https://doi.org/10.3390/antiox12081578
Vancouver
Pintye D, Sziva RE, Mastyugin M, Török M, Jacas S, Lo A, et al. Nitroxide—HMP—Protects Human Trophoblast HTR-8/SVneo Cells from H2O2-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway. Antioxidants. 2023;12(8):1578. doi:10.3390/antiox12081578
BibTeX
@article{Pintye2023,
author = {Pintye, Diana and Sziva, Réka Eszter and Mastyugin, Maxim and Török, Marianna and Jacas, Sonako and Lo, Agnes and Salahuddin, Saira and Zsengellér, Zsuzsanna K},
title = {Nitroxide—HMP—Protects Human Trophoblast HTR-8/SVneo Cells from H2O2-Induced Oxidative Stress by Reducing the HIF1A Signaling Pathway},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {8},
pages = {1578},
doi = {10.3390/antiox12081578}
}
EUVIMED